Inpatient Expenditures Attributable to Hospital-Onset Clostridium Difficile Infection: A Nationwide Case-Control Study in Japan

Overview

Journal Pharmacoeconomics

Specialty Pharmacology

Date 2018 Jul 20

PMID 30022364

Citations 4

Authors

Haruhisa Fukuda

Takahisa Yano

Nobuyuki Shimono

Affiliations

Soon will be listed here.

Abstract

Background: Hospital-onset Clostridium difficile infections (CDIs) have a considerable clinical and economic impact on patients and payers. Quantifying the economic impact of CDIs can guide treatment strategies. However, previous studies have generally focused on acute care hospitals, and few have included cost estimates from non-acute care hospitals such as long-term care facilities.

Aim: This study aimed to quantify the hospital-onset CDI-attributable inpatient expenditures and length-of-stay durations in all healthcare institutions that provide inpatient care (including acute and non-acute care) in Japan.

Methods: Using national-level insurance claims data, we analyzed patients who had been hospitalized between April 2010 and December 2016. CDI cases were identified and matched with non-CDI controls using hospitalization year, treating hospital, age, sex, surgical procedure, comorbidities, and main diagnoses. Through multivariable regression analyses, we estimated the CDI-attributable inpatient expenditures (2016 US dollars) and length-of-stay durations (days) while adjusting for variations in factors such as patient characteristics, comorbidities, surgery, prescribed antibiotic, geographic region, and hospitalization year. We also analyzed the CDI-attributable inpatient expenditures and length-of-stay durations according to hospital type (acute care and rehabilitation/long-term care).

Results: The analysis was conducted using 3768 matched pairs. Overall, CDI-attributable inpatient expenditures and length-of-stay durations were US$3213 and 11.96 days, respectively. Rehabilitation/long-term care hospitals had substantially higher inpatient expenditures and longer hospitalizations than acute care hospitals.

Conclusion: This study quantified the hospital-onset CDI-attributable inpatient expenditures and hospitalizations in both acute and non-acute care hospitals. The inclusion of non-acute care hospitals provides a more accurate representation of the economic burden of CDIs.

Citing Articles

Validation of Lyophilized Human Fecal Microbiota for the Treatment of Infection: A Pilot Study with Pharmacoeconomic Analysis of a Middle-Income Country-Promicrobioma Project.

Yamada C, Ortis G, Buso G, Martins T, Zequinao T, Telles J Microorganisms. 2024; 12(8).

PMID: 39203583 PMC: 11356882. DOI: 10.3390/microorganisms12081741.

Budget Impact Analysis of Adopting a One-Step Nucleic Acid Amplification Testing (NAAT) Alone Diagnostic Pathway for in Japan Compared to a Two-Step Algorithm with Glutamate Dehydrogenase/Toxin Followed by NAAT.

Lim V, Tomaru T, Chua B, Ma Y, Yanagihara K Diagnostics (Basel). 2023; 13(8).

PMID: 37189564 PMC: 10137341. DOI: 10.3390/diagnostics13081463.

Excess length of hospital stay, mortality and cost attributable to () infection and recurrence: a nationwide analysis in Japan.

Kimura T, Stanhope S, Sugitani T Epidemiol Infect. 2020; 148:e65.

PMID: 32115019 PMC: 7118723. DOI: 10.1017/S0950268820000606.

Efficacy of prolonged tapered and pulsed vancomycin regimen on recurrent infection in the Japanese setting: a case control study.

Umemura T, Ota A, Mutoh Y, Norizuki C, Mizuno T, Kozaki K J Pharm Health Care Sci. 2019; 5:19.

PMID: 31410293 PMC: 6686363. DOI: 10.1186/s40780-019-0147-1.

References

Vonberg R, Reichardt C, Behnke M, Schwab F, Zindler S, Gastmeier P . Costs of nosocomial Clostridium difficile-associated diarrhoea. J Hosp Infect. 2008; 70(1):15-20. DOI: 10.1016/j.jhin.2008.05.004. View

Campbell R, Giljahn L, Machesky K, Cibulskas-White K, Lane L, Porter K . Clostridium difficile infection in Ohio hospitals and nursing homes during 2006. Infect Control Hosp Epidemiol. 2009; 30(6):526-33. DOI: 10.1086/597507. View

Kim J, Toy D, Muder R . Clostridium difficile infection in a long-term care facility: hospital-associated illness compared with long-term care-associated illness. Infect Control Hosp Epidemiol. 2011; 32(7):656-60. DOI: 10.1086/660767. View

Song X, Bartlett J, Speck K, Naegeli A, Carroll K, Perl T . Rising economic impact of clostridium difficile-associated disease in adult hospitalized patient population. Infect Control Hosp Epidemiol. 2008; 29(9):823-8. DOI: 10.1086/588756. View

Tabak Y, Zilberberg M, Johannes R, Sun X, McDonald L . Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study. Infect Control Hosp Epidemiol. 2013; 34(6):588-96. DOI: 10.1086/670621. View

Burton H, Mitchell S, Watt M . A Systematic Literature Review of Economic Evaluations of Antibiotic Treatments for Clostridium difficile Infection. Pharmacoeconomics. 2017; 35(11):1123-1140. PMC: 5656734. DOI: 10.1007/s40273-017-0540-2. View

van Kleef E, Green N, Goldenberg S, Robotham J, Cookson B, Jit M . Excess length of stay and mortality due to Clostridium difficile infection: a multi-state modelling approach. J Hosp Infect. 2014; 88(4):213-7. DOI: 10.1016/j.jhin.2014.08.008. View

Quan H, Li B, Couris C, Fushimi K, Graham P, Hider P . Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011; 173(6):676-82. DOI: 10.1093/aje/kwq433. View

Asensio A, Di Bella S, Lo Vecchio A, Grau S, Hart W, Isidoro B . The impact of Clostridium difficile infection on resource use and costs in hospitals in Spain and Italy: a matched cohort study. Int J Infect Dis. 2015; 36:31-8. DOI: 10.1016/j.ijid.2015.05.013. View

10.

Magee G, Strauss M, Thomas S, Brown H, Baumer D, Broderick K . Impact of Clostridium difficile-associated diarrhea on acute care length of stay, hospital costs, and readmission: A multicenter retrospective study of inpatients, 2009-2011. Am J Infect Control. 2015; 43(11):1148-53. DOI: 10.1016/j.ajic.2015.06.004. View

11.

Mitchell B, Gardner A, Barnett A, Hiller J, Graves N . The prolongation of length of stay because of Clostridium difficile infection. Am J Infect Control. 2013; 42(2):164-7. DOI: 10.1016/j.ajic.2013.07.006. View

12.

Kyne L, Hamel M, Polavaram R, Kelly C . Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis. 2002; 34(3):346-53. DOI: 10.1086/338260. View

13.

Heimann S, Vehreschild J, Cornely O, Wisplinghoff H, Hallek M, Goldbrunner R . Economic burden of Clostridium difficile associated diarrhoea: a cost-of-illness study from a German tertiary care hospital. Infection. 2015; 43(6):707-14. DOI: 10.1007/s15010-015-0810-x. View

14.

McDonald L, Coignard B, Dubberke E, Song X, Horan T, Kutty P . Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol. 2007; 28(2):140-5. DOI: 10.1086/511798. View

15.

Bauer M, Notermans D, van Benthem B, Brazier J, Wilcox M, Rupnik M . Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2010; 377(9759):63-73. DOI: 10.1016/S0140-6736(10)61266-4. View

16.

van Walraven C, Austin P, Jennings A, Quan H, Forster A . A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009; 47(6):626-33. DOI: 10.1097/MLR.0b013e31819432e5. View

17.

Yasunaga H, Horiguchi H, Hashimoto H, Matsuda S, Fushimi K . The burden of Clostridium difficile-associated disease following digestive tract surgery in Japan. J Hosp Infect. 2012; 82(3):175-80. DOI: 10.1016/j.jhin.2012.07.023. View

18.

Yu H, Baser O, Wang L . Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort study. BMC Geriatr. 2016; 16(1):193. PMC: 5123396. DOI: 10.1186/s12877-016-0367-2. View

19.

Cohen S, Gerding D, Johnson S, Kelly C, Loo V, McDonald L . Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010; 31(5):431-55. DOI: 10.1086/651706. View

20.

Stevens V, Khader K, Nelson R, Jones M, Rubin M, Brown K . Excess Length of Stay Attributable to Clostridium difficile Infection (CDI) in the Acute Care Setting: A Multistate Model. Infect Control Hosp Epidemiol. 2015; 36(9):1024-30. DOI: 10.1017/ice.2015.132. View